Liver disease (hepatitis, cirrhosis) Board decisions

The Board found that the appellant's hepatitis C was not incurred during active service and denied his claim.

The case is being returned to the RO for further evidentiary development, including scheduling a Travel Board hearing at the Newark, New Jersey RO.

The Board denied service connection for hepatitis C and skin cancer, finding no evidence of current disabilities or a link to service.

The Board has determined that new and material evidence has not been presented to reopen the claim of service connection for the cause of the Veteran's death. The appellant submitted lay testimony and duplicative medical records, which were considered in previous decisions. There is no new evidence showing a causal relationship between any service-connected disability and the Veteran's death.

The Veteran's claim for service connection for hepatitis C is being remanded due to the need for additional medical examination and consideration of all relevant factors, including his history of intravenous drug use and blood transfusions.

The Board found that the Veteran's death was not due to negligent treatment received at VA facilities, and therefore denied DIC under 38 U.S.C.A. § 1151.

The Board has determined that the Veteran's death was caused by hepatitis C, which is service-connected as it occurred during his military service.

The Veteran's hepatitis C is currently rated at 40 percent from December 16, 2005. The Board found that the criteria for a higher rating were not met prior to March 21, 2005.

The Board is reopening the claim for service connection for hepatitis C and remanding it to the RO for further development. The Veteran's claims for alcohol abuse and PTSD are being remanded as well.

The Veteran's claims for service connection were denied across multiple conditions, including PTSD, chloracne, hypertension, hepatitis C infection, and a lung disability. The Board found no evidence linking these conditions to service or herbicide exposure.

The Board denied service connection for an acquired psychiatric disorder, including PTSD, and hepatitis A and C due to lack of verified in-service stressors and no causal link to service. The Veteran's reported combat experiences were not corroborated by service records.

The Board found that the evidence received since the July 1977 rating decision did not relate to an unestablished fact necessary to substantiate the claim of service connection for residuals of nerve gas exposure, and thus denied reopening of this claim. The Veteran's claim for hepatitis C was also denied.

The Board denied the Veteran's claims for hepatitis C, tinea cruris, and diabetes mellitus. The appeal is not about service connection at all.

The Board has remanded the case due to the need for additional development, including obtaining medical records and conducting a VA examination.

The Veteran's claim for compensation under 38 U.S.C.A. § 1151 for hepatitis C was denied as there is no evidence to support a causal relationship between the Veteran's hepatitis C and VA treatment.

The Veteran's claim for service connection for hepatitis C is being remanded due to the need for additional development, including obtaining SSA records and scheduling a VA examination.

The Veteran meets the criteria for a total disability rating for nonservice-connected pension purposes due to multiple disabilities, including his right knee and low back conditions.

The Veteran's claims for service connection for high blood pressure, high cholesterol, persistent hepatitis, and an unspecified joint disability were denied. The effective date of the increased rating for low back strain was set at November 12, 2003.

The Board denied the Veteran's claims for service connection for bilateral hearing loss and hepatitis C, as well as his claim for an increased evaluation for residuals of right inguinal hernia repair with scarring. The evidence did not meet the threshold requirements for a disability due to impaired hearing under VA regulations.

The Board has determined that additional evidentiary development is necessary prior to the adjudication of the appellant's claims for hepatitis C and bilateral hearing loss.